Funder
Auckland Medical Research Foundation
Health Research Council
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Warton, S., Sibley, C., & Heazell, A. (2014). Understanding the placental aetiology of fetal growth restriction; could this lead to personalied management strategies? Fetal and Maternal Medicine Review, 25(2), 95–116.
2. Abrahams, V. M., Chamley, L. W., & Salmon, J. E. (2017). Emerging treatment models in rheumatology: antiphospholipid syndrome and pregnancy: Pathogenesis to translation [in eng]. Arthritis & rheumatology (Hoboken, NJ), 69(9), 1710–1721.
3. Chen, H. Y., Chauhan, S. P., Ward, T. C., et al. (2011). Aberrant fetal growth and early, late, and postneonatal mortality: an analysis of Milwaukee births, 1996–2007. Am J Obstet Gynecol, 204(3), 261 e261–261 e210.
4. Gardosi, J., Clausson, B., & Francis, A. (2009). The value of customised centiles in assessing perinatal mortality risk associated with parity and maternal size. BJOG, 116(10), 1356–1363.
5. Lappen, J. R., & Myers, S. A. (2017). The systematic error in the estimation of fetal weight and the underestimation of fetal growth restriction [in eng]. American Journal of Obstetrics and Gynecology, 216, 477–483.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献